New product innovation with core focus on scalable solutions across 23 publications and timely, topical editorially-driven programs. Industry Dive is a leading business journalism company. More than 11 million decision-makers across 20 competitive industries rely on its exclusive insight and analysis delivered through 23 publications. Industry Dive was founded in 2012 to provide business leaders with the information they need to move industries forward. Our team of reporters, editors, designers, and marketers deliver insights and programs that spark innovation, fuel growth and shape agendas in every industry we cover.

Research Director for CFO & The Argyle Group Expertise on the corporate finance function and CFO strategies across sectors and organization sizes.- Oversee bespoke client-facing engagements from proposal/bid phase to survey/screener development, field management, data processing, statistical analysis, report writing, and presenting findings with deliverables.- Scaled research and advisory solutions across executive community channels (CHRO, CIO/CISO, and CMO/CX) with direct top-line revenue impact.- Member of Executive Management Committee, reporting directly to the Chairman and CEO with P&L ownership of Research and Custom Content lines of business. - Led initiatives for guidance on business development, change management, internal strategy, and growth.- Managed cross-functional teams to execute CFO Live, a two-day, multi-stage conference, drawing over 300 corporate finance executive attendees, and generating highest sponsorship revenue in company history. - Concurrently fulfilled Director of Marketing & Campaign Management role from 03/2020-08/2020.- Managed a team of 9 direct reports and cohort of freelance writers, designers, programmers, and analyst.- Completed novel market sizing assessment for the organization (first-ever) of identifying key MSAs with clusters of executives in the mid-market to enterprise level, fueling annual live event strategy. - Acquired by Industry Dive Q4 2020

Manage strategic engagements for private equity and life sciences portfolio companies spanning: - Commercial due diligence - Growth strategy- M&A-related strategy consulting- Market assessment Engagements spanned across deal cycle, from pre-LOI to PMI

Core member of the North America Financial Services (NAFS) Healthcare, Hedge Funds practice - Book of business consisted of global long/short, macro, directional, event-driven, state endowments, and arbitrage focused Hedge Funds - Partner directly with portfolio managers to execute time sensitive engagements to execute investment strategies across medical device, biopharma, health tech, and healthcare service companies.

The Translational Genome Editing lab is focused on establishing robust CRISPR-mediated methods for the genetic manipulation of human-induced pluripotent stem cells (hiPSC) and the newly discovered human liver-derived ductal stem cells. We use human liver-derived ductal stem cells to study liver regenerative medicine and liver gene therapy, as well as cardiovascular and liver disease-associated gene mutations.The Translational Genome Editing lab, led by Dr. Tobias Raabe, Ph.D. is focused on:Establishing robust CRISPR-mediated methods for the genetic manipulation of human-induced pluripotent stem cells (hiPSC) and of the newly discovered human liver-derived ductal stem cells.The functional study of cardiovascular and liver disease associated gene mutations using induced hepatocytes derived from human liver-derived ductal stem cells.The use of human liver-derived ductal stem cells for liver regenerative medicine and liver gene therapy.We are especially interested in isolating and characterizing adult liver-derived ductal stem cells, which are bi-potent cells that can give rise to either bile ducts or to hepatocytes, depending on their ex vivo or in vivo environment. We use special culture conditions that allow derivation of these resident ductal stem cells from adult mouse and, importantly, human liver without artificial transgene-based immortalization. These culture conditions allow for continuous 3D culture of the ductal stem cells for more than one year with a 10-fold higher genetic stability compared to iPSC. The human liver derived ductal stem cells are physiologically and genetically virtually identical to their precursors in the parental liver tissue and thus may yield more patient-relevant data compared to other cell types that have been traditionally used for the study of liver genetics, metabolism and disease.+ Robust expertise designing CRISPR/Cas9 – mediated gene targeting using viral vectors.

- Family office invested in limited-service, extended stay, and boutique hotel portfolio across NJ & PA. - P&L responsibility with direct inventory, rate, marketing, and strategic oversight. - Oversaw acquisition and investment strategies with 12-month turnaround plans for properties. - Led property improvement imitative, including studs down renovations.- Set new terms with 3 OTAs with direct top-line impact within 60-days and undertook strategic partnerships for corporate bookings with local firms and businesses.- Consistently increased revPAR, ADR, occupancy and established properties as leaders in comp set.